Daly P A
Am J Med Sci. 1980 Nov-Dec;280(3):130-42. doi: 10.1097/00000441-198011000-00001.
The increased availability of platelets for transfusion has been a major factor in the improved prognosis noted in patients with acute nonlymphocytic leukemia. This review summarizes our current understanding of the proper use of platelet transfusion for patients with leukemia and cancer, with a particular emphasis on the management of alloimmunized patients. The need for careful and close collaboration between the blood bank and the referring clinicians is emphasized. Cryopreservation of autologous platelets, which can be of considerable assistance in the management of alloimmunized patients, and a summary of the large number of questions that still require further investigation are presented.
可用于输血的血小板数量增加，是急性非淋巴细胞白血病患者预后改善的一个主要因素。本综述总结了我们目前对白血病和癌症患者正确使用血小板输血的认识，尤其着重于对同种免疫患者的管理。强调了血库与转诊临床医生之间密切合作的必要性。介绍了自体血小板的冷冻保存（这对同种免疫患者的管理有很大帮助）以及大量仍需进一步研究的问题总结。
